Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G McHutchison

Showing results (1-10 of 251) with videos related to

Pageof 26
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
The role of genetic markers in hepatitis C virus therapy: a major step for individualized careJohn G McHutchison
The American Journal of Managed Care|April 16, 2004
Understanding hepatitis CJohn G McHutchison
Journal of Gastroenterology and Hepatology|May 2, 2002
Hepatitis C advances in antiviral therapy: what is accepted treatment now?John G McHutchison
Postgraduate Medicine|July 24, 2003
Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patientsKeyur Patel, John G McHutchison
Hepatology (Baltimore, Md.)|October 31, 2002
Future therapy of hepatitis CJohn G McHutchison, Keyur Patel
Cleveland Clinic Journal of Medicine|October 8, 2004
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and durationKeyur Patel, John G McHutchison
Seminars in Hematology|July 13, 2010
Use of thrombopoietic agents for the thrombocytopenia of liver diseaseHans L Tillmann, John G McHutchison
The American Journal of Managed Care|April 16, 2004
Hepatitis C: a 20-year debt comes dueJohn G McHutchison, Bruce R Bacon
Clinics in Liver Disease|April 15, 2003
Current therapy for hepatitis C: pegylated interferon and ribavirinJohn G McHutchison, Michael W Fried
Hepatology (Baltimore, Md.)|February 10, 2004
Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003Jean-Michel Pawlotsky, John G McHutchison
Pageof 26

Showing results (1-10 of 251) with videos related to

Sort By:
Pageof 26
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
The role of genetic markers in hepatitis C virus therapy: a major step for individualized careJohn G McHutchison
The American Journal of Managed Care|April 16, 2004
Understanding hepatitis CJohn G McHutchison
Journal of Gastroenterology and Hepatology|May 2, 2002
Hepatitis C advances in antiviral therapy: what is accepted treatment now?John G McHutchison
Postgraduate Medicine|July 24, 2003
Current therapies for chronic hepatitis C. Drug combination achieves sustained response in more than half of patientsKeyur Patel, John G McHutchison
Hepatology (Baltimore, Md.)|October 31, 2002
Future therapy of hepatitis CJohn G McHutchison, Keyur Patel
Cleveland Clinic Journal of Medicine|October 8, 2004
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and durationKeyur Patel, John G McHutchison
Seminars in Hematology|July 13, 2010
Use of thrombopoietic agents for the thrombocytopenia of liver diseaseHans L Tillmann, John G McHutchison
The American Journal of Managed Care|April 16, 2004
Hepatitis C: a 20-year debt comes dueJohn G McHutchison, Bruce R Bacon
Clinics in Liver Disease|April 15, 2003
Current therapy for hepatitis C: pegylated interferon and ribavirinJohn G McHutchison, Michael W Fried
Hepatology (Baltimore, Md.)|February 10, 2004
Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003Jean-Michel Pawlotsky, John G McHutchison
Pageof 26